"Receptors, Interleukin-2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Receptors present on activated T-LYMPHOCYTES and B-LYMPHOCYTES that are specific for INTERLEUKIN-2 and play an important role in LYMPHOCYTE ACTIVATION. They are heterotrimeric proteins consisting of the INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT, the INTERLEUKIN-2 RECEPTOR BETA SUBUNIT, and the INTERLEUKIN RECEPTOR COMMON GAMMA-CHAIN.
Descriptor ID |
D015375
|
MeSH Number(s) |
D12.776.543.750.705.852.420.320
|
Concept/Terms |
Receptors, Interleukin-2- Receptors, Interleukin-2
- Receptors, Interleukin 2
- TCGF Receptor
- TCGF Receptors
- Receptors, TCGF
- IL-2 Receptor
- IL 2 Receptor
- Receptor, IL-2
- IL-2 Receptors
- IL 2 Receptors
- T-Cell Growth Factor Receptor
- T Cell Growth Factor Receptor
- IL2 Receptors
- Receptors, IL2
- Interleukin 2 Receptor
- Receptor, Interleukin 2
- Interleukin-2 Receptors
- Interleukin 2 Receptors
- Receptor, TCGF
- Receptors, IL-2
- Receptors, IL 2
- Receptors, T-Cell Growth Factor
- Receptors, T Cell Growth Factor
- T-Cell Growth Factor Receptors
- T Cell Growth Factor Receptors
- IL2 Receptor
- Receptor, IL2
|
Below are MeSH descriptors whose meaning is more general than "Receptors, Interleukin-2".
Below are MeSH descriptors whose meaning is more specific than "Receptors, Interleukin-2".
This graph shows the total number of publications written about "Receptors, Interleukin-2" by people in this website by year, and whether "Receptors, Interleukin-2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Below are the most recent publications written about "Receptors, Interleukin-2" by people in Profiles.
-
Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease. Cancer Epidemiol Biomarkers Prev. 1997 Oct; 6(10):807-13.